The rising demand for biopharmaceuticals and vaccines can be attributed to several interconnected factors. Firstly, advances in biotechnology and genomics have transformed the pharmaceutical industry. Techniques such as CRISPR-Cas9 have revolutionized gene editing, enabling the development of highly targeted treatments and vaccines. Secondly, increasing global health concerns, exemplified by the COVID-19 pandemic, have underscored the necessity of vaccines in controlling infectious diseases. Additionally, the emergence of antibiotic-resistant bacteria highlights the importance of continuous research and development in biopharmaceuticals and vaccines.
For instance,
when the novel coronavirus SARS-CoV-2 emerged in late 2019, it quickly spread globally, causing a severe respiratory illness known as COVID-19. The rapid spread of the virus highlighted the urgent need for vaccines and treatments.
Thus increasing demand for biopharmaceuticals and vaccines is expected to drive market growth.
Access Full Report @ https://www.databridgemarketresearch.com/fr/reports/global-ultra-low-freezers-market
Data Bridge Market Research analyzes that the Global Ultra Low Freezers Market is expected to grow with a CAGR of 5.4% in the forecast period of 2023 to 2030 and is expected to reach USD 909.26 million by 2030. The product segment is projected to propel the market growth and increasing applications of ultra low freezers worldwide.
Key Findings of the Study
Increasing demand for biopreservation and biobanking
Ultra low freezers are vital components in the biobanking infrastructure, providing the necessary storage conditions for preserving a wide range of biological samples. As biobanking facilities proliferate globally due to advancements in medical research, precision medicine, and pharmaceutical development, the demand for ultra low freezers is surging. Manufacturers in this market have the chance to innovate and offer advanced freezer models with features such as energy efficiency and remote monitoring to meet the evolving needs of biobanks. In addition, the global expansion of biobanking facilities means that manufacturers can target a broad and diverse customer base, including emerging markets where investment in biobanking infrastructure is on the rise. Customized solutions, compliance features, and sustainability considerations further enhance the opportunities for growth in the ultra low freezers market, making it a promising sector for manufacturers.
Thus, the increasing demand for biopreservation and biobanking is expected to drive market growth.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million
|
|
Segments Covered
|
Type (Product and Freezer Part and Accessories), Technology (Semi-Automated Freezers and Automated Freezers), Degree of Cooling (-41°C to -86°C Freezers, -87°C to -150°C Freezers, and -10°C to -40°C Freezers), Insulated Material (Polyurethane Foam, Vacuum Panels, and Others), Application (Organs, Blood & Blood Products, Biological Samples, Drug Compounds, and Others), End User (Hospitals, Bio-Banks, Clinics, Corporate Laboratories, Pharmaceuticals Companies, Academic and Research Institutes, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Third Party Distributors)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, U.K., France, Italy, Russia, Spain, Netherlands, Switzerland, Belgium, Turkey, Rest of Europe, China, Japan, India, Australia, South Korea, Indonesia, Philippines, Thailand, Malaysia, Singapore, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, U.A.E., Egypt, Israel, and Rest of Middle East and Africa
|
|
Market Players Covered
|
Thermo Fisher Scientific Inc. (U.S.), Helmer Scientific Inc. (U.S.), BINDER GmbH (Germany), Esco Micro Pte. Ltd. (Singapore), NuAire, Inc. (U.S.), LABCOLD (U.K.), BioLife Solutions Inc. (U.S.), PHC Corporation (Japan), REMI GROUP. (India), FUKUSHIMA GALILEI CO.LTD. (Japan), ARCTIKO (Denmark), EVERMED s.r.l. (Italy), AticoExport (India), Vestfrost Solutions (Denmark), BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD. (India), Eppendorf SE (Germany), VWR International, LLC. (U.S.), Telstar, B Medical Systems (Luxembourg), and Bioway Corporation (China), among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis
The global ultra low freezers market is categorized into seven notable segments on the basis of type, technology, degree of cooling, insulated material, application, end user, and distribution channel.
- On the basis of type, the market is segmented into product and freezer parts and accessories.
In 2023, the product segment is expected to dominate the global ultra low freezers market
In 2023, the product segment is expected to dominate the market with 94.83% market share due to rising technological advancement by manufacturers to improve temperature control, energy efficiency, and reliability of the freezers.
- On the basis of technology, the market is segmented into automated freezers and semi-automated freezers.
In 2023, the automated freezers segment is expected to dominate the global ultra low freezers market
In 2023, the automated freezers segment is expected to dominate the market with 63.49% market share as automated ultra-low freezers offer precise and consistent temperature control and monitoring.
- On the basis of degree of cooling, the market is segmented into automated -41°C to -86°C freezers, -87°C to -150°C freezers, and -10°C to -40°C freezers. In 2023, the -41°C to -86°C freezers segment is expected to dominate the market with 82.29% market share.
- On the basis of insulated material, the market is segmented into polyurethane foam, vacuum panels, and others. In 2023, the polyurethane foam segment is expected to dominate the market with 65.10% market share.
- On the basis of application, the market is segmented into blood & blood products, biological samples, drug compounds, organs, and others. In 2023, the blood & blood products segment is expected to dominate the market with 46.43% market share.
- On the basis of end user, the market is segmented into hospitals, corporate laboratories, pharmaceuticals companies, bio-banks, clinics, academic and research institutes, and others. In 2023, the hospitals segment is expected to dominate the market with 34.78% market share.
- On the basis of distribution channel, the market is segmented into direct tenders, retail sales, and third party distributors. In 2023, the direct tenders segment is expected to dominate the market with 63.41% market share.
Major Players
Data Bridge Market Research recognizes the following companies as the market players in the global ultra low freezers market that include Thermo Fisher Scientific Inc. (U.S.), BioLife Solutions Inc. (U.S.), PHC Corporation (Japan), Eppendorf SE (Germany), VWR International, LLC. (U.S.), among others.
Market Development
- In June 2023, BioLife Solutions, Inc., a leading developer and supplier of biotechnology products and services for Cell and Gene Therapy (CGT) and broader biopharmaceutical markets announced the launch of a new High Capacity Controlled Freezer (CRF) to expand its CRF range, now available in three different formats. This IntelliRate i67C benchtop freezer meets important customer needs for large-scale production of cell therapies.
- In April 2023, Eppendorf launched the Centrifuge 5427 R, the first hydrocarbon-cooled Eppendorf microcentrifuge that contributed to a more sustainable laboratory environment. With this offer, customers can now perform a variety of molecular and cell biology applications using a refrigeration unit that contains a natural refrigerant with near-zero global warming potential. This launch not only the individuals but also the planet.
- In October 2022, Thermo Fisher Scientific Inc. announced that it would expand its laboratory operations in Highland Heights, Kentucky, helping customers deliver life-changing medicines to patients. The current facility, which includes central lab and biomarker operations, provides biopharma customers with high-quality laboratory services to accelerate drug development. This will help the company expand its clinical diagnostics business across various regions in the world and help to increase its global presence in the market.
- In March 2021, Helmer Scientific is pleased to announce the launch of the GX solutions laboratory and plasma freezer for vaccines, medicines, blood therapy, and specimen storage. Powered by OptiCool technology, GX Solutions is the first professional medical freezer optimized for critical healthcare applications thanks to temperature performance, noise reduction, and lower energy consumption. At the same time, they use low global warming potential (GWP) technology to support environmental sustainability. This launch has helped the company to expand its freezers product portfolio.
- In September 2020, PHC Corporation announced the acquisition of 50.9% of the shares of Amelieff Corporation according to an agreement with the company, which according to Amelieff operates as a consolidated subsidiary of PHC Corporation. This acquisition will help PHC Corporation strengthen its healthcare services business.
Geographical Analysis
Geographically, the countries covered in the ultra low freezers market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Russia, Spain, Netherlands, Switzerland, Belgium, Turkey, Rest of Europe, China, Japan, India, Australia, South Korea, Indonesia, Philippines, Thailand, Malaysia, Singapore, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, U.A.E., Egypt, Israel, and Rest of Middle East and Africa.
As per Data Bridge Market Research analysis:
North America is the dominant region in global ultra low freezers market
North America is expected to dominate the market owing to the higher level of investments by manufacturers and the increasing application of ultra low freezers for refrigeration. North America will continue to dominate the ultra low freezers market in terms of market share and market revenue. This is due to the growing adoption of advanced technology and the launch of new products globally. Additionally, the increasing demand for ultra low freezers and advancement in ultra low freezers are expected to further enhance the market's growth.
Asia-Pacific is estimated to be the fastest-growing region in the market during the forecast period 2023-2030.
Asia-Pacific is expected to grow during the forecast period due to the presence of major market players and rapid development in pharmaceutical and biotechnological industries in this region. In addition to this, rising strategic initiatives by major market players in the region are expected to drive market growth.
For more detailed information about the ultra low freezers market report, click here – https://www.databridgemarketresearch.com/fr/reports/global-ultra-low-freezers-market
